ScoreWhy is Supriya Lifescience Ltd ?
1
High Management Efficiency with a high ROE of 16.77%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
With a growth in Net Sales of 11.77%, the company declared Very Positive results in Dec 24
- The company has declared positive results for the last 5 consecutive quarters
- PAT(HY) At Rs 92.93 cr has Grown at 73.15 %
- NET SALES(HY) At Rs 351.75 cr has Grown at 25.55 %
- PBDIT(Q) Highest at Rs 65.95 cr.
4
Stock is technically in a Mildly Bullish range
- The stocks DOW and OBV technical factors are also Bullish
5
Majority shareholders : Promoters
6
Market Beating performance in long term as well as near term
- Along with generating 86.77% returns in the last 1 year, the stock has outperformed BSE 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Supriya Lifesci. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Supriya Lifesci. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Supriya Lifesci.
87.3%
1.59
54.56%
SENSEX
0.45%
0.04
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.08%
EBIT Growth (5y)
6.27%
EBIT to Interest (avg)
69.41
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.70
Tax Ratio
26.55%
Dividend Payout Ratio
5.41%
Pledged Shares
0
Institutional Holding
11.44%
ROCE (avg)
28.88%
ROE (avg)
16.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
33
Price to Book Value
5.88
EV to EBIT
22.79
EV to EBITDA
21.12
EV to Capital Employed
6.35
EV to Sales
7.83
PEG Ratio
0.68
Dividend Yield
0.12%
ROCE (Latest)
25.02%
ROE (Latest)
19.26%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
PAT(HY)
At Rs 92.93 cr has Grown at 73.15 %
NET SALES(HY)
At Rs 351.75 cr has Grown at 25.55 %
PBDIT(Q)
Highest at Rs 65.95 cr.
PBT LESS OI(Q)
Highest at Rs 60.48 cr.
EPS(Q)
Highest at Rs 5.81
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Supriya Lifesci.
Net Sales - Quarterly
Highest at Rs 185.65 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 65.95 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 60.48 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 46.78 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 5.81
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
